Eventide Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-95,781
Closed -$17.3M 245
2025
Q1
$17.3M Hold
95,781
0.34% 95
2024
Q4
$15M Hold
95,781
0.27% 112
2024
Q3
$17.4M Sell
95,781
-40,704
-30% -$7.41M 0.3% 97
2024
Q2
$25.1M Hold
136,485
0.43% 76
2024
Q1
$24.3M Hold
136,485
0.38% 81
2023
Q4
$16.9M Buy
+136,485
New +$16.9M 0.28% 95